Viruses,
Journal Year:
2024,
Volume and Issue:
16(1), P. 100 - 100
Published: Jan. 9, 2024
SARS-CoV-2
caused
the
COVID-19
pandemic.
may
elevate
risk
of
cognitive
impairment
and
even
cause
dementia
in
infected
individuals;
it
accelerate
decline
elderly
patients
with
dementia,
possibly
Alzheimer's
disease
(AD)
patients.
However,
mechanisms
underlying
interplay
between
AD
are
still
unclear.
To
investigate
associations
progression
infection,
we
conducted
a
series
bioinformatics
research
into
SARS-CoV-2-infected
cells,
patients,
We
identified
common
differentially
expressed
genes
(DEGs)
these
DEGs
enriched
certain
pathways,
such
as
immune
responses
cytokine
storms.
constructed
gene
interaction
network
signaling
transduction
module
center
Nature Cell Biology,
Journal Year:
2023,
Volume and Issue:
25(4), P. 550 - 564
Published: March 9, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
the
RNA
virus
responsible
for
disease
2019
(COVID-19)
pandemic.
Although
SARS-CoV-2
was
reported
to
alter
several
cellular
pathways,
its
impact
on
DNA
integrity
and
mechanisms
involved
remain
unknown.
Here
we
show
that
causes
damage
elicits
an
altered
response.
Mechanistically,
proteins
ORF6
NSP13
cause
degradation
of
response
kinase
CHK1
through
proteasome
autophagy,
respectively.
loss
leads
deoxynucleoside
triphosphate
(dNTP)
shortage,
causing
impaired
S-phase
progression,
damage,
pro-inflammatory
pathways
activation
senescence.
Supplementation
deoxynucleosides
reduces
that.
Furthermore,
N-protein
impairs
53BP1
focal
recruitment
by
interfering
with
damage-induced
long
non-coding
RNAs,
thus
reducing
repair.
Key
observations
are
recapitulated
in
SARS-CoV-2-infected
mice
patients
COVID-19.
We
propose
SARS-CoV-2,
boosting
ribonucleoside
levels
promote
replication
at
expense
dNTPs
hijacking
RNAs'
biology,
threatens
genome
activation,
induction
inflammation
Brain,
Journal Year:
2022,
Volume and Issue:
145(9), P. 3203 - 3213
Published: Feb. 4, 2022
Abstract
While
neuropathological
examinations
in
patients
who
died
from
COVID-19
revealed
inflammatory
changes
cerebral
white
matter,
MRI
frequently
fails
to
detect
abnormalities
even
the
presence
of
neurological
symptoms.
Application
multi-compartment
diffusion
microstructure
imaging
(DMI),
that
detects
small
volume
shifts
between
compartments
(intra-axonal,
extra-axonal
and
free
water/CSF)
a
matter
model,
is
promising
approach
overcome
this
discrepancy.
In
monocentric
prospective
study,
cohort
20
inpatients
(57.3
±
17.1
years)
with
symptoms
(e.g.
delirium,
cranial
nerve
palsies)
cognitive
impairments
measured
by
Montreal
Cognitive
Assessment
(MoCA
test;
22.4
4.9;
70%
below
cut-off
value
<26/30
points)
underwent
DMI
subacute
stage
disease
(29.3
14.8
days
after
positive
PCR).
A
comparison
whole-brain
parameters
matched
healthy
control
group
(n
=
35)
shift
intra-
space
into
water
fraction
(V-CSF).
This
widespread
COVID-related
V-CSF
increase
affected
entire
supratentorial
maxima
frontal
parietal
regions.
Streamline-wise
comparisons
controls
further
network
most
fibres
connecting
cortical
regions
all
lobes.
The
magnitude
these
(V-CSF)
was
associated
impairment
MoCA
test
(r
−0.64,
P
0.006)
but
not
olfactory
performance
0.29,
0.12).
Furthermore,
non-significant
trend
for
an
association
interleukin-6
emerged
0.48,
0.068),
prominent
marker
related
response.
14/20
also
received
18F-FDG
PET,
expression
previously
defined
COVID-19-related
metabolic
spatial
covariance
pattern
0.57;
0.039).
addition,
frontoparietal-dominant
neocortical
glucose
hypometabolism
well
focus
increase.
summary,
compatible
vasogenic
oedema,
affecting
various
tracts.
These
were
PET
imaging.
Aging Cell,
Journal Year:
2023,
Volume and Issue:
22(5)
Published: March 23, 2023
Abstract
We
examine
similar
and
differential
effects
of
two
senolytic
treatments,
ABT‐263
dasatinib
+
quercetin
(D
Q),
in
preserving
cognition,
markers
peripheral
senescence,
brain
aging
thought
to
underlie
cognitive
decline.
Male
F344
rats
were
treated
from
12
18
months
age
with
D
Q,
ABT‐263,
or
vehicle,
compared
young
(6
months).
Both
treatments
rescued
memory,
preserved
the
blood–brain
barrier
(BBB)
integrity,
prevented
age‐related
decline
hippocampal
N‐methyl‐D‐aspartate
receptor
(NMDAR)
function
associated
impaired
cognition.
Senolytic
decreased
senescence‐associated
secretory
phenotype
(SASP)
inflammatory
cytokines/chemokines
plasma
(IL‐1β,
IP‐10,
RANTES),
some
more
responsive
Q
(TNFα)
(IFNγ,
leptin,
EGF).
was
effective
decreasing
senescence
genes
spleen.
expression
immune
response
oxidative
stress
increased
synaptic
dentate
gyrus
(DG).
However,
influenced
twice
as
many
ABT‐263.
Relative
group
exhibited
DG
linked
cell
death
negative
regulation
apoptosis
microglial
activation.
Furthermore,
at
morphological
The
results
indicate
that
cognition
removal
senescent
cells,
systemic
inflammation
normally
drives
neuroinflammation,
BBB
breakdown,
function.
Dissimilarities
transcription
divergence
central
mechanisms,
possibly
due
access.
Cell Reports Medicine,
Journal Year:
2023,
Volume and Issue:
4(11), P. 101254 - 101254
Published: Oct. 26, 2023
The
post-acute
sequelae
of
COVID-19
(PASC),
also
known
as
long
COVID,
is
often
associated
with
debilitating
symptoms
and
adverse
multisystem
consequences.
We
obtain
plasma
samples
from
117
individuals
during
6
months
following
their
acute
phase
infection
to
comprehensively
profile
assess
changes
in
cytokines,
proteome,
metabolome.
Network
analysis
reveals
sustained
inflammatory
response,
platelet
degranulation,
cellular
activation
convalescence
accompanied
by
dysregulation
arginine
biosynthesis,
methionine
metabolism,
taurine
tricarboxylic
acid
(TCA)
cycle
processes.
Furthermore,
we
develop
a
prognostic
model
composed
20
molecules
involved
regulating
T
cell
exhaustion
energy
metabolism
that
can
reliably
predict
clinical
outcomes
discharge
83%
accuracy
an
area
under
the
curve
(AUC)
0.96.
Our
study
pertinent
biological
processes
differ
infection,
it
supports
development
specific
therapies
biomarkers
for
patients
suffering
COVID.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(9), P. 3190 - 3190
Published: April 28, 2023
Numerous
investigations
have
demonstrated
significant
and
long-lasting
neurological
manifestations
of
COVID-19.
It
has
been
suggested
that
as
many
four
out
five
patients
who
sustained
COVID-19
will
show
one
or
several
symptoms
can
last
months
after
the
infection
run
its
course.
Neurological
are
most
common
in
people
less
than
60
years
age,
while
encephalopathy
is
more
those
over
60.
Biological
mechanisms
for
these
need
to
be
investigated
may
include
both
direct
indirect
effects
virus
on
brain
spinal
cord.
Individuals
with
Alzheimer’s
disease
(AD)
related
dementia,
well
persons
Down
syndrome
(DS),
especially
vulnerable
COVID-19,
but
biological
reasons
this
not
clear.
Investigating
consequences
an
urgent
emerging
medical
need,
since
close
700
million
worldwide
now
had
at
least
once.
likely
there
a
new
burden
healthcare
economy
dealing
long-term
severe
SARS-CoV-2
infections
long
COVID,
even
younger
generations.
Interestingly,
acute
strikingly
similar
observed
mild
traumatic
injury
(mTBI)
concussion,
including
dizziness,
balance
issues,
anosmia,
headaches.
The
possible
convergence
pathways
involved
discussed.
current
review
focused
commonly
described
symptoms,
molecular
involved.
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Sept. 28, 2023
Approximately
one
third
of
non-hospitalized
coronavirus
disease
2019
(COVID-19)
patients
report
chronic
symptoms
after
recovering
from
the
acute
stage
severe
respiratory
syndrome
2
(SARS-CoV-2)
infection.
Some
most
persistent
and
common
complaints
this
post-acute
COVID-19
(PACS)
are
cognitive
in
nature,
described
subjectively
as
“brain
fog”
also
objectively
measured
deficits
executive
function,
working
memory,
attention,
processing
speed.
The
mechanisms
these
sequelae
currently
not
understood.
SARS-CoV-2
inflicts
damage
to
cerebral
blood
vessels
intestinal
wall
by
binding
angiotensin-converting
enzyme
(ACE2)
receptors
evoking
production
high
levels
systemic
cytokines,
compromising
brain’s
neurovascular
unit,
degrading
barrier,
potentially
increasing
permeability
both
harmful
substances.
Such
substances
hypothesized
be
produced
gut
pathogenic
microbiota
that,
given
profound
effects
has
on
gastrointestinal
system,
may
fourish
a
result
post-COVID-19
dysbiosis.
therefore
create
scenario
which
neurotoxic
neuroinflammatory
readily
proliferate
lumen
encounter
weakened
gaining
access
brain
subsequently
producing
deficits.
Here,
we
review
proposed
PACS
pathogenesis
along
gut-brain
axis,
while
identifying
specific
methodologies
that
available
experimentally
measure
each
individual
component
model.